Drawing for C

USPTO serial 78447755

C

Reviewed by CopyMark Law Group

Reg. 3014168Status 710
Filing date
Status date
Registration date
Nov 8, 2005
Examiner
BELLO, ZACK
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with C?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb CompanyPO BOX 4000Trademark Dept., Mailstop D.4243PRINCETON, NJ 08648

Goods and services

ClassDescriptionStatusFirst use
005biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriological culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune systemSECTION 8 - CANCELLEDSep 29, 1998
040custom synthesis of DNA to the order and specification of others; custom manufacturing services [, namely, manufacturing agrochemicals to the specification of others ]SECTION 8 - CANCELLEDSep 29, 1998
042research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for othersSECTION 8 - CANCELLEDSep 29, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 8, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 9, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 9, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 9, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 28, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 29, 2014NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Nov 29, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Nov 29, 201489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Nov 29, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 10, 2014E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 29, 2010C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 29, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 9, 2010E815TEAS SECTION 8 & 15 RECEIVED—
Nov 8, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2005REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Sep 16, 2005ALIEASSIGNED TO LIE—
Sep 9, 2005CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 9, 2005SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 25, 2005IUAFUSE AMENDMENT FILED—
Aug 25, 2005EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 2, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 2005CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 16, 2005COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 10, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2005NPUBNOTICE OF PUBLICATION—
Jan 25, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 21, 2005ALIEASSIGNED TO LIE—
Jan 14, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 10, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2005GNPEEXAMINER'S AMENDMENT AND/OR PRIORITY ACTION E-MAILED—
Jan 8, 2005CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 7, 2005DOCKASSIGNED TO EXAMINER—
Jul 15, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance